Search
NEWS

Bev Shea – OMERACT

By A Mystery Man Writer

Bev Shea – OMERACT

PDF) Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group

Bev Shea – OMERACT

IJMS, Free Full-Text

Bev Shea – OMERACT

Late-Stage Knee and Hip Osteoarthritis Composite Measure – OMERACT

Bev Shea – OMERACT

(PDF) Improving social justice in observational studies: protocol for the development of a global and Indigenous STROBE-equity reporting guideline

Bev Shea – OMERACT

Safety – OMERACT

Bev Shea – OMERACT

Bev Shea – OMERACT

Bev Shea – OMERACT

Psoriatic Arthritis Impact of Disease (PsAID12) Was Provisionally Endorsed at Omeract 2018 As Core Instrument to Measure Psoriatic Arthritis-Specific Health-Related Quality of Life in Randomized Controlled Trials and Longitudinal Observational Studies

Bev Shea – OMERACT

IJERPH, Free Full-Text

Bev Shea – OMERACT

PDF) Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group

Bev Shea – OMERACT

Improving social justice in observational studies: protocol for the development of a global and Indigenous STROBE-equity reporting guideline, International Journal for Equity in Health

Bev Shea – OMERACT

OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods study - ScienceDirect

Bev Shea – OMERACT

PDF) Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop

Bev Shea – OMERACT

The 66/68 Joint Count for the Measurement of MSK Disease Activity/Peripheral Joint Activity in Psa: A Grappa-Omeract Working Group Initiative - ACR Meeting Abstracts

Bev Shea – OMERACT

Myositis – OMERACT